Akriveia Therapeutics, LLC — Form D
Akriveia Therapeutics, LLC of SKILLMAN, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-31. The offering totals $22.5M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-01-31
- Form: D
- Accession: 0001676950-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $22.5M
- Amount sold: $3.0M
- Remaining: $19.5M
- Investors: 1
- Date of first sale: 2018-01-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-304462
Issuer
- Name: Akriveia Therapeutics, LLC
- CIK: 0001676950
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 23 SOUTHERN HILLS DRIVE, SKILLMAN, NJ, 08558
- Phone: 609-560-0927
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Benjamin Auspitz | Director | Skillman, NJ |
| Thomas Beck | Director | Milwaukee, WI |
| Michael Gladstone | Director | Cambridge, MA |
| David Grayzel | Director | Cambridge, MA |
| Simon Tomlinson | Director | Skillman, NJ |
| Simon Tomlinson | Executive Officer | Skillman, NJ |
Other filings by this issuer (1)
More